111 related articles for article (PubMed ID: 23314696)
1. A recombined fusion protein PTD-Grb2-SH2 inhibits the proliferation of breast cancer cells in vitro.
Yin J; Cai Z; Zhang L; Zhang J; He X; Du X; Wang Q; Lu J
Int J Oncol; 2013 Mar; 42(3):1061-9. PubMed ID: 23314696
[TBL] [Abstract][Full Text] [Related]
2. Recombinant fusion proteins FPTD-Grb2-SH2 and FPTD-Grb2-SH2M inhibit the proliferation of breast cancer cells in vitro.
Yin J; Yuan L; Liu Z; Zhang F; He X; Xu Z; Wang Q; Du X; Wu X; Lu J
Oncol Rep; 2014 Jun; 31(6):2669-75. PubMed ID: 24715105
[TBL] [Abstract][Full Text] [Related]
3. Growth of chronic myeloid leukemia cells is inhibited by infection with Ad-SH2-HA adenovirus that disrupts Grb2-Bcr-Abl complexes.
Peng Z; Luo HW; Yuan Y; Shi J; Huang SF; Li CL; Cao WX; Huang ZG; Feng WL
Oncol Rep; 2011 May; 25(5):1381-8. PubMed ID: 21369701
[TBL] [Abstract][Full Text] [Related]
4. Fusion protein based on Grb2-SH2 domain for cancer therapy.
Saito Y; Furukawa T; Arano Y; Fujibayashi Y; Saga T
Biochem Biophys Res Commun; 2010 Aug; 399(2):262-7. PubMed ID: 20655296
[TBL] [Abstract][Full Text] [Related]
5. Effects of peptidic antagonists of Grb2-SH2 on human breast cancer cells.
Chen CH; Chen MK; Jeng KC; Lung FD
Protein Pept Lett; 2010 Jan; 17(1):44-53. PubMed ID: 19508206
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a novel nonphosphorylated pentapeptide motif displaying high affinity for Grb2-SH2 domain by the utilization of 3'-substituted tyrosine derivatives.
Song YL; Peach ML; Roller PP; Qiu S; Wang S; Long YQ
J Med Chem; 2006 Mar; 49(5):1585-96. PubMed ID: 16509576
[TBL] [Abstract][Full Text] [Related]
7. Development of non-peptide ligands of growth factor receptor-bound protein 2-SRC homology 2 domain using molecular modeling and NMR spectroscopy.
Orcajo-Rincón ÁL; Ortega-Gutiérrez S; Serrano P; Torrecillas IR; Wüthrich K; Campillo M; Pardo L; Viso A; Benhamú B; López-Rodríguez ML
J Med Chem; 2011 Feb; 54(4):1096-100. PubMed ID: 21271718
[TBL] [Abstract][Full Text] [Related]
8. Nuclear magnetic resonance solution structure of the growth factor receptor-bound protein 2 Src homology 2 domain.
Thornton KH; Mueller WT; McConnell P; Zhu G; Saltiel AR; Thanabal V
Biochemistry; 1996 Sep; 35(36):11852-64. PubMed ID: 8794768
[TBL] [Abstract][Full Text] [Related]
9. The amino-terminal Src homology 2 domain of phospholipase C gamma 1 is essential for TCR-induced tyrosine phosphorylation of phospholipase C gamma 1.
Stoica B; DeBell KE; Graham L; Rellahan BL; Alava MA; Laborda J; Bonvini E
J Immunol; 1998 Feb; 160(3):1059-66. PubMed ID: 9570517
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 TAT protein transduction domain mediates enhancement of enzyme prodrug cancer gene therapy in vitro: a study with TAT-TK-GFP triple fusion construct.
Meriläinen O; Hakkarainen T; Wahlfors T; Pellinen R; Wahlfors J
Int J Oncol; 2005 Jul; 27(1):203-8. PubMed ID: 15942661
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the Grb2 gene in human breast cancer cell lines.
Daly RJ; Binder MD; Sutherland RL
Oncogene; 1994 Sep; 9(9):2723-7. PubMed ID: 8058337
[TBL] [Abstract][Full Text] [Related]
12. Macrocyclization in the design of Grb2 SH2 domain-binding ligands exhibiting high potency in whole-cell systems.
Wei CQ; Gao Y; Lee K; Guo R; Li B; Zhang M; Yang D; Burke TR
J Med Chem; 2003 Jan; 46(2):244-54. PubMed ID: 12519063
[TBL] [Abstract][Full Text] [Related]
13. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
[TBL] [Abstract][Full Text] [Related]
14. Potent inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands.
Yao ZJ; King CR; Cao T; Kelley J; Milne GW; Voigt JH; Burke TR
J Med Chem; 1999 Jan; 42(1):25-35. PubMed ID: 9888830
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine phosphorylation of a 94-kDa protein associated with GRB2/ASH is implicated in the signal transduction of hematopoietic survival factors.
Hanazono Y; Sasaki K; Odai H; Yazaki Y; Hirai H
Biochem Biophys Res Commun; 1996 May; 222(2):330-7. PubMed ID: 8670205
[TBL] [Abstract][Full Text] [Related]
16. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
17. Dynamin II associates with Grb2 SH3 domain in Ras transformed NIH3T3 cells.
Yoon SY; Koh WS; Lee MK; Park YM; Han MY
Biochem Biophys Res Commun; 1997 May; 234(3):539-43. PubMed ID: 9175747
[TBL] [Abstract][Full Text] [Related]
18. Interaction of the non-phosphorylated peptide G7-18NATE with Grb7-SH2 domain requires phosphate for enhanced affinity and specificity.
Gunzburg MJ; Ambaye ND; Del Borgo MP; Pero SC; Krag DN; Wilce MC; Wilce JA
J Mol Recognit; 2012 Jan; 25(1):57-67. PubMed ID: 22213451
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of a C-terminally biotinylated macrocyclic peptide mimetic exhibiting high Grb2 SH2 domain-binding affinity.
Shi ZD; Liu H; Zhang M; Worthy KM; Bindu L; Yang D; Fisher RJ; Burke TR
Bioorg Med Chem; 2005 Jul; 13(13):4200-8. PubMed ID: 15893931
[TBL] [Abstract][Full Text] [Related]
20. Grb2 SH2 domain-binding peptide analogs as potential anticancer agents.
Lung FD; Tsai JY
Biopolymers; 2003; 71(2):132-40. PubMed ID: 12767115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
